Halozyme Therapeutics Inc. (HALO)

$ 75.64
   
  • Change Today:
    $-1.93
  • 52 Week High: $78.33
  • 52 Week Low: $42.57
  • Currency: US Dollars
  • Shares Issued: 145.30m
  • Volume: 2,228,714
  • Market Cap: $10,990m
  • RiskGrade: 189

Financial Analysis

Select chart: EPS | Revenue

Key Fundamentals

Fundamentals data is not available for this company.

Forecasts

Year Ending Revenue ($m) Pre-tax ($m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-25 1,320.08 826.35 616.50¢ 12.3 n/a n/a n/a 0.0%
31-Dec-26 1,626.20 1,080.66 796.60¢ 9.5 0.3 +29% n/a 0.0%
31-Dec-27 1,910.54 1,364.11 978.50¢ 7.7 0.3 +23% n/a 0.0%

Copyright © 2025 FactSet Research Systems Inc. All rights reserved.

Price / Earnings Data

5 Yr High 5 Yr Low 5 Yr Avg Curr / Avg
Latest n/a n/a n/a 0

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Forecast figures based on normalised accounts.

 

HALO Market Data

Currency US Dollars
Share Price $ 75.64
Change Today $ -1.93
% Change -2.49 %
52 Week High $78.33
52 Week Low $42.57
Volume 2,228,714
Shares Issued 145.30m
Market Cap $10,990m
RiskGrade 189

What The Brokers Say

Strong Buy 0
Buy 5
Neutral 3
Sell 1
Strong Sell 0
Total 9
neutral
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Trades for 24-Sep-2025

Time Volume / Share Price
15:59 100 @ $75.66
15:59 163 @ $75.66
15:59 100 @ $75.65
15:59 169 @ $75.65
15:59 100 @ $75.64

Top of Page